Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (211-220 of 450) with videos related to

Pageof 45
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 28, 2007
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cellsDaniele Simoni, Michele Rizzi, Riccardo Rondanin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 10, 2019
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivorsRaffaele Giusti, Emanuela Scarpi, Katia Cannita, et al.
BMC Cancer|September 29, 2018
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA projectGiacomo Pelizzari, Grazia Arpino, Laura Biganzoli, et al.
Frontiers in Oncology|May 10, 2021
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical PracticeMichela Roberto, Andrea Botticelli, Martina Panebianco, et al.
Psychology & Health|November 13, 2015
Being positive despite illness: The contribution of positivity to the quality of life of cancer patientsGian Vittorio Caprara, Valeria Castellani, Guido Alessandri, et al.
Ebiomedicine|April 27, 2022
Immune effects of CDK4/6 inhibitors in patients with HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: Relief from immunosuppression is associated with clinical responseFabio Scirocchi, Simone Scagnoli, Andrea Botticelli, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
Medical Oncology (Northwood, London, England)|February 2, 2015
Continuous, low-dose capecitabine for patients with recurrent colorectal cancerAdriana Romiti, Concetta Elisa Onesti, Michela Roberto, et al.
Bioorganic Chemistry|December 3, 2021
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virusValentina Gentili, Giulia Turrin, Paolo Marchetti, et al.
Pharmacogenomics and Personalized Medicine|August 13, 2021
Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling ProcessMarina Borro, Giovanna Gentile, Sally H Preissner, et al.
Pageof 45

Showing results (211-220 of 450) with videos related to

Sort By:
Pageof 45
Bioorganic & Medicinal Chemistry Letters|November 28, 2007
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cellsDaniele Simoni, Michele Rizzi, Riccardo Rondanin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 10, 2019
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivorsRaffaele Giusti, Emanuela Scarpi, Katia Cannita, et al.
BMC Cancer|September 29, 2018
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA projectGiacomo Pelizzari, Grazia Arpino, Laura Biganzoli, et al.
Frontiers in Oncology|May 10, 2021
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical PracticeMichela Roberto, Andrea Botticelli, Martina Panebianco, et al.
Psychology & Health|November 13, 2015
Being positive despite illness: The contribution of positivity to the quality of life of cancer patientsGian Vittorio Caprara, Valeria Castellani, Guido Alessandri, et al.
Ebiomedicine|April 27, 2022
Immune effects of CDK4/6 inhibitors in patients with HR<sup>+</sup>/HER2<sup>-</sup> metastatic breast cancer: Relief from immunosuppression is associated with clinical responseFabio Scirocchi, Simone Scagnoli, Andrea Botticelli, et al.
Critical Reviews in Oncology/Hematology|December 4, 2020
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectivesDaniele Marinelli, Raffaele Giusti, Marco Mazzotta, et al.
Medical Oncology (Northwood, London, England)|February 2, 2015
Continuous, low-dose capecitabine for patients with recurrent colorectal cancerAdriana Romiti, Concetta Elisa Onesti, Michela Roberto, et al.
Bioorganic Chemistry|December 3, 2021
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virusValentina Gentili, Giulia Turrin, Paolo Marchetti, et al.
Pharmacogenomics and Personalized Medicine|August 13, 2021
Individualized Drugs' Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling ProcessMarina Borro, Giovanna Gentile, Sally H Preissner, et al.
Pageof 45